Literature DB >> 24482698

Salivary sIg-A response against the recombinant Ag38 antigen of Mycobacterium tuberculosis Indonesian strain.

Tri Yudani Mardining Raras1, Gamal Sholeh2, Diana Lyrawati3.   

Abstract

An evaluation of the humoral response based on secretory immunoglobulin A levels in the saliva of pulmonary tuberculosis (TB) acid-fast bacillus-positive (TB-AFB+) patients against a recombinant 38 kDa antigen (Ag38-rec) is reported. A total of 60 saliva samples consist of 30 TB-AFB+ patients and 30 healthy controls were tested against 500 ng of semi-purified antigen using the dot blot method. Results showed that the protein antigen could differentiate between healthy individuals and TB-AFB(+) patients. Whole saliva demonstrated better reactivity than centrifuged saliva. The Ag38-rec protein indicated statistically comparable sensitivity (80% versus 90%), but lower specificity (36.6% versus 70%) compared with purified protein derivative (PPD). Surprisingly, both antigens similarly recognized secretory immunoglobulin A in the saliva of the healthy group (50% versus 50%, respectively). These findings suggest that the Ag38-rec protein originating from a local strain of Mycobacterium tuberculosis may be used for TB screening, however require purity improvement.

Entities:  

Keywords:  Secretory Ig-A; antigen 38 recombinant; saliva

Year:  2014        PMID: 24482698      PMCID: PMC3902250     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  20 in total

1.  Specific and early detection of IgG, IgA and IgM antibodies to Mycobacterium tuberculosis 38kDa antigen in pulmonary tuberculosis.

Authors:  K R Uma Devi; B Ramalingam; P J Brennan; P R Narayanan; A Raja
Journal:  Tuberculosis (Edinb)       Date:  2001       Impact factor: 3.131

2.  A comparison of seven tests for serological diagnosis of tuberculosis.

Authors:  S Pottumarthy; V C Wells; A J Morris
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

Review 3.  Oral mucosal immunology: an overview.

Authors:  D M Walker
Journal:  Ann Acad Med Singapore       Date:  2004-07       Impact factor: 2.473

4.  Evaluation of the recombinant 38-kilodalton antigen of Mycobacterium tuberculosis as a potential immunodiagnostic reagent.

Authors:  R J Wilkinson; K Hasløv; R Rappuoli; F Giovannoni; P R Narayanan; C R Desai; H M Vordermeier; J Paulsen; G Pasvol; J Ivanyi; M Singh
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

5.  Serodiagnosis of tuberculosis. A study comparing three specific mycobacterial antigens.

Authors:  I H Chiang; J Suo; K J Bai; T P Lin; K T Luh; C J Yu; P C Yang
Journal:  Am J Respir Crit Care Med       Date:  1997-09       Impact factor: 21.405

Review 6.  Immunodiagnostic assays for tuberculosis and leprosy.

Authors:  J Ivanyi; G H Bothamley; P S Jackett
Journal:  Br Med Bull       Date:  1988-07       Impact factor: 4.291

7.  Detection of histidine rich protein 2 and panmalarial ICT Malaria Pf/Pv test antigens after chloroquine treatment of uncomplicated falciparum malaria does not reliably predict treatment outcome in eastern Indonesia.

Authors:  E Tjitra; S Suprianto; M E Dyer; B J Currie; N M Anstey
Journal:  Am J Trop Med Hyg       Date:  2001-11       Impact factor: 2.345

8.  Humoral immune response against 38-kDa and 16-kDa mycobacterial antigens in bone and joint tuberculosis.

Authors:  U Demkow; T M Zielonka; M Nowak-Misiak; M Filewska; B Bialas; J Strzalkowski; K Rapala; Z Zwolska; E Skopinska-Rozewska
Journal:  Int J Tuberc Lung Dis       Date:  2002-11       Impact factor: 2.373

9.  Salivary IgA in response to periodontal treatment.

Authors:  Stefan J Hägewald; Daniel L W Fishel; Claudia E B Christan; Jean-Pierre Bernimoulin; Andreas Kage
Journal:  Eur J Oral Sci       Date:  2003-06       Impact factor: 2.612

10.  Serologic diagnosis of bone and joint tuberculosis by an enzyme-linked immunosorbent assay.

Authors:  A B Stroebel; T M Daniel; J H Lau; J C Leong; H Richardson
Journal:  J Infect Dis       Date:  1982-08       Impact factor: 5.226

View more
  1 in total

1.  IMMUNE RESPONSE UPON THE ADMINISTRATION OF RECOMBINANT PROTEIN ANTIBODIES Ag-38 KDa Mycobacterium tuberculosis AND RIFAMPICIN EX-VIVO.

Authors:  Tri Yudani Mardining Raras; Almira Fahrinda; Dwi Yuni Nurhidayati; Hidayat Sujuti; Sumarno Reto Prawiro
Journal:  Afr J Infect Dis       Date:  2022-05-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.